以岭药业：12月5日召开董事会会议

Group 1 - Yiling Pharmaceutical (SZ 002603) announced on December 5 that its 19th board meeting of the 8th session was held on the same day, where it reviewed the proposal for the second extraordinary general meeting of shareholders in 2025 [1] - For the first half of 2025, Yiling Pharmaceutical's revenue composition is 100% from the pharmaceutical manufacturing industry [1] - As of the report date, Yiling Pharmaceutical has a market capitalization of 30.4 billion yuan [1] Group 2 - Large bank certificates of deposit have become a scarce resource, with products offering over 2% interest rates being difficult to obtain, and some requiring a high minimum investment of 10 million yuan [1] - Experts suggest that deposit interest rates may trend downward in the long term [1]